WHO ICTRP trial
Efficacy, safety, and compliance comparison of vonoprazan combined with…
ChiCTR2200063796 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200063796 |
|---|---|
| Public title | Efficacy, safety, and compliance comparison of vonoprazan combined with different doses of amoxicillin dual therapy for eradication of Helicobacter pylori in the elderly: a prospective, multicenter, randomized controlled study |
| Scientific title | Efficacy, safety, and compliance comparison of vonoprazan combined with different doses of amoxicillin dual therapy for eradication of Helicobacter pylori in the elderly: a prospective, multicenter, randomized controlled study |
| Primary sponsor | Lanzhou University Second Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Helicobacter pylori |
| Interventions | Group 1 :amoxicillin 750 mg qid + vonoprazan 20 mg bid;Group 2:amoxicillin 500 mg qid + vonoprazan 20 mg bid;Group 3:amoxicillin 1 g tid + vonoprazan 20 mg bid |
| Registration date | Sep 16, 2022 |
| Target size | Group 1 :140;Group 2:140;Group 3:140 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: